We’re not sure how everyone else feels but from our perspective the business of diabetes has reached the crossroads. Think of everything that is happening now;
1. We are quickly reaching the point thanks to these sophisticated algorithms when diabetes management could become much easier and not just for insulin using patients. It’s a major mistake to believe that these algorithms can only help insulin using patients.
2. The payor landscape will NEVER be the same and this will have a dramatic impact on the business of diabetes. As we have seen everyone is making deals in the . . .
This content is restricted to subscribers. Please subscribe.
Already have an account? Please login.
